Low frequency and rare coding variation contributes to multiple sclerosis risk

Mitja Mitrovič, Nikolaos A. Patsopoulos, Ashley Beecham, Theresa Dankowski, An Goris, Bénédicte Dubois, Marie D’hooghe, Robin Lemmens, Philip Van Damme, Kate Fitzgerald, Helle Bach Søndergaard, Finn Sellebjerg, Per Soelberg Sørensen, Henrik Ullum, Lise Wegner Thoerner, Thomas Werge, Janna Saarela, Isabelle Cournu‐Rebeix, Vincent Damotte, Bertrand Fontaine, Léna Guillot‐Noël, Mark Lathrop, Sandra Vukusik, Pierre‐Antoine Gourraud, Till F. M. Andlauer, Viola Pongratz, Dorothea Buck, Christiane Gasperi, Christiane Graetz, Antonios Bayas, Christoph Heesen, Tania Kümpfel, Ralf A. Linker, Friedemann Paul, Martin Stangel, Björn Tackenberg, Florian Then Bergh, Clemens Warnke, Heinz Wiendl, Brigitte Wildemann, Uwe K. Zettl, Ulf Ziemann, Hayrettin Tumani, Ralf Gold, Verena Grummel, Bernhard Hemmer, Benjamin Knier, Christina M. Lill, Efthimios Luessi, Efthimios Dardiotis, Cristina Agliardi, Nadia Barizzone, Elisabetta Mascia, Luisa Bernardinelli, Gıancarlo Comı, Daniele Cusi, Federica Esposito, Laura Ferrè, Cristoforo Comi, Daniela Galimberti, Maurizio Leone, Melissa Sorosina, Julia Mescheriakova, Rogier Hintzen, Cornelia M. van Duijn, Steffan D. Bos, Kjell‐Morten Myhr, Elisabeth Gulowsen Celius, Benedicte A. Lie, Anne Spurkland, Manuel Comabella, Xavier Montalbán, Lars Alfredsson, Pernilla Stridh, Jan Hillert, Maja Jagodic, Fredrik Piehl, Ilijas Jelčić, Roland Martinꝉ, Mireia Sospedra, Maria Ban, Clive Hawkins, Pirro G. Hysi, Seema Kalra, Fredrik Karpe, Jyoti Khadake, Geneviève Lachance, Matthew Neville, Adam Santaniello, Stacy J. Caillier, Peter A. Calabresi, Bruce Cree, Anne H. Cross, Mary F. Davis, Jonathan L. Haines, Paul I. W. de Bakker, Silvia Delgado, Marieme Dembele, Keith R. Edwards, Håkon HåkonarsonbioRxiv 2018 · DOI

TL;DR

This study reveals that low-frequency and rare genetic variants, previously overlooked by common variant GWAS, explain a significant portion of multiple sclerosis (MS) heritability. By analyzing a large dataset of cases and controls, the researchers identified novel genes involved in immune regulation, offering new avenues for understanding MS pathogenesis.

What Problem Does This Paper Address?

Multiple sclerosis (MS) is a complex neurological disease with a substantial genetic component, but a significant portion of its heritability remains unexplained by common genetic variants identified through genome-wide association studies (GWAS). While common variants account for about 20% of MS heritability, the remaining heritability is thought to be due to additive effects of other variants, rather than complex interactions or rare family-specific mutations. This paper tackles the challenge of identifying the source of this "missing heritability," specifically focusing on the contribution of low-frequency (MAF 0.0001-5%) and rare coding variants, which are often not well-captured by standard GWAS arrays due to their low frequency and limited linkage disequilibrium with common variants.

Methods

The researchers conducted a large-scale meta-analysis of low-frequency coding variants across all autosomal exons. They utilized a dataset of 68,379 MS cases and 36,012 controls, genotyped using Illumina HumanExome Beadchips or a custom array incorporating exome chip content.

Key methodological steps included:

  • Genotyping and Quality Control: Rigorous quality control was applied to filter samples and variants, including checks for genotyping rate, heterozygosity, sex concordance, relatedness, population stratification (using principal component analysis), and Hardy-Weinberg equilibrium.
  • Low-Frequency Variant Calling: They employed both Illumina's standard GenCall algorithm and zCall, a specialized algorithm for calling low-frequency variants.
  • Association Analysis: Linear mixed models, implemented in GCTA, were used for association analysis within each of 13 country-level strata. This approach accounts for population structure and genetic relatedness.
  • Meta-Analysis: Association statistics from the strata were combined using inverse-variance-weighted meta-analysis. A Bonferroni correction was applied for multiple testing to establish a genome-wide significance threshold.
  • Heritability Estimation: GCTA was also used to estimate the heritability explained by different variant frequency categories (common, intermediate, and rare) using both two-component and three-component models.

Datasets

The study utilized a large, multi-cohort dataset comprising:

  • MS Cases and Controls: A total of 68,379 MS cases and 32,367 MS cases and 36,012 controls were analyzed. These samples were drawn from Australia, ten European countries, and multiple US states.
  • Exome Chip Data: Genotyping was performed using Illumina HumanExome Beadchips or a custom array.
  • ExAC Database: The Exome Aggregation Consortium (ExAC) database was used to assess the coverage of the exome chip for low-frequency missense variants.

Key Insights and Ideas

  • Low-frequency variants are significant contributors to MS risk: The study provides strong evidence that variants with minor allele frequencies (MAF) below 5% are not just noise but actively contribute to MS heritability, a finding that has been difficult to ascertain with traditional GWAS.
  • Coding variants are key: By focusing on non-synonymous coding variants, the researchers increased the likelihood of identifying variants with a direct phenotypic impact, making their findings more interpretable and experimentally tractable.
  • Novel genes highlight immune pathways: The identification of four novel genes associated with MS risk points to critical roles for T cell homeostasis, IFNγ biology, and NFκB signaling in the pathogenesis of the disease. This moves beyond previously identified loci and suggests new therapeutic targets.
  • Low linkage disequilibrium simplifies interpretation: The finding that these low-frequency variants show minimal linkage disequilibrium with common variants means their effects are likely independent, making it easier to pinpoint the causal genes and understand their specific contributions.

Key Results

  • Heritability Explained: Low-frequency coding variants explain approximately 5% of MS heritability. Specifically, rare variants (MAF < 1%) alone account for about 3.2% of heritability on the liability scale.
  • Novel Gene Discoveries: Seven low-frequency coding variants in six genes outside the extended MHC locus were found to be significantly associated with MS risk. Four of these genes represent novel associations.
  • Functional Relevance: The identified genes are involved in key immunological pathways, including perforin-mediated cytotoxicity (PRF1), T regulatory cell development (HDAC7), interferon signaling (PRKRA), and NFκB signaling.

Limitations and Future Work

  • Detectability Threshold: While the study identified significant associations, the authors acknowledge that they cannot detect all low-frequency variants at genome-wide significance, even with a large sample size. Many rare variants likely contribute to MS risk but are individually below the statistical threshold for detection.
  • Exome Chip Coverage: The exome chip captures a substantial fraction of low-frequency missense variants but has lower coverage for very rare alleles, meaning the heritability estimates for the rarest variants might be conservative.
  • Future Directions: The identified genes and pathways provide a rich resource for future research into the pathobiology of MS. Further experimental validation of these variants and genes, and exploration of their functional mechanisms, are crucial next steps. The study also suggests that future genetic studies should continue to prioritize the investigation of low-frequency and rare variants to fully unravel the genetic architecture of complex diseases like MS.

Summary updated

Abstract

Abstract Multiple sclerosis is a common, complex neurological disease, where almost 20% of risk heritability can be attributed to common genetic variants, including &gt;230 identified by genome-wide association studies (Patsopoulos et al., 2017). Multiple strands of evidence suggest that the majority of the remaining heritability is also due to the additive effects of individual variants, rather than epistatic interactions between these variants, or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that as much as 5% of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common variant signals, which highlight a key role for regulatory T cell homeostasis and regulation, IFNγ biology and NFκB signaling in MS pathogenesis. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS.
BibTeX
@misc{mitrovic2018low,
  author = {Mitja Mitrovič and Nikolaos A. Patsopoulos and Ashley Beecham and Theresa Dankowski and An Goris and Bénédicte Dubois and Marie D’hooghe and Robin Lemmens and Philip Van Damme and Kate Fitzgerald and Helle Bach Søndergaard and Finn Sellebjerg and Per Soelberg Sørensen and Henrik Ullum and Lise Wegner Thoerner and Thomas Werge and Janna Saarela and Isabelle Cournu‐Rebeix and Vincent Damotte and Bertrand Fontaine and Léna Guillot‐Noël and Mark Lathrop and Sandra Vukusik and Pierre‐Antoine Gourraud and Till F. M. Andlauer and Viola Pongratz and Dorothea Buck and Christiane Gasperi and Christiane Graetz and Antonios Bayas and Christoph Heesen and Tania Kümpfel and Ralf A. Linker and Friedemann Paul and Martin Stangel and Björn Tackenberg and Florian Then Bergh and Clemens Warnke and Heinz Wiendl and Brigitte Wildemann and Uwe K. Zettl and Ulf Ziemann and Hayrettin Tumani and Ralf Gold and Verena Grummel and Bernhard Hemmer and Benjamin Knier and Christina M. Lill and Efthimios Luessi and Efthimios Dardiotis and Cristina Agliardi and Nadia Barizzone and Elisabetta Mascia and Luisa Bernardinelli and Gıancarlo Comı and Daniele Cusi and Federica Esposito and Laura Ferrè and Cristoforo Comi and Daniela Galimberti and Maurizio Leone and Melissa Sorosina and Julia Mescheriakova and Rogier Hintzen and Cornelia M. van Duijn and Steffan D. Bos and Kjell‐Morten Myhr and Elisabeth Gulowsen Celius and Benedicte A. Lie and Anne Spurkland and Manuel Comabella and Xavier Montalbán and Lars Alfredsson and Pernilla Stridh and Jan Hillert and Maja Jagodic and Fredrik Piehl and Ilijas Jelčić and Roland Martinꝉ and Mireia Sospedra and Maria Ban and Clive Hawkins and Pirro G. Hysi and Seema Kalra and Fredrik Karpe and Jyoti Khadake and Geneviève Lachance and Matthew Neville and Adam Santaniello and Stacy J. Caillier and Peter A. Calabresi and Bruce Cree and Anne H. Cross and Mary F. Davis and Jonathan L. Haines and Paul I. W. de Bakker and Silvia Delgado and Marieme Dembele and Keith R. Edwards and Håkon Håkonarson},
  title = {{Low frequency and rare coding variation contributes to multiple sclerosis risk}},
  year = {2018},
  doi = {10.1101/286617},
  howpublished = {bioRxiv},
}
Figure